[go: up one dir, main page]

SI1476196T1 - Zmes trdne raztopine v vodi slabo topne aktivne substance za oralno uporabo - Google Patents

Zmes trdne raztopine v vodi slabo topne aktivne substance za oralno uporabo

Info

Publication number
SI1476196T1
SI1476196T1 SI200330630T SI200330630T SI1476196T1 SI 1476196 T1 SI1476196 T1 SI 1476196T1 SI 200330630 T SI200330630 T SI 200330630T SI 200330630 T SI200330630 T SI 200330630T SI 1476196 T1 SI1476196 T1 SI 1476196T1
Authority
SI
Slovenia
Prior art keywords
active substance
solid solution
poorly water
oral solid
soluble active
Prior art date
Application number
SI200330630T
Other languages
English (en)
Inventor
Henricus R M Gorissen
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of SI1476196T1 publication Critical patent/SI1476196T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200330630T 2002-02-14 2003-02-11 Zmes trdne raztopine v vodi slabo topne aktivne substance za oralno uporabo SI1476196T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075623 2002-02-14
EP03706620A EP1476196B1 (en) 2002-02-14 2003-02-11 Oral solid solution formulation of a poorly water-soluble active substance
PCT/EP2003/050014 WO2003068266A1 (en) 2002-02-14 2003-02-11 Oral solid solution formulation of a poorly water-soluble active substance

Publications (1)

Publication Number Publication Date
SI1476196T1 true SI1476196T1 (sl) 2007-04-30

Family

ID=27619166

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330630T SI1476196T1 (sl) 2002-02-14 2003-02-11 Zmes trdne raztopine v vodi slabo topne aktivne substance za oralno uporabo

Country Status (24)

Country Link
US (2) US20050008697A1 (sl)
EP (1) EP1476196B1 (sl)
JP (1) JP2005517041A (sl)
KR (1) KR101014545B1 (sl)
CN (1) CN1273194C (sl)
AR (1) AR038681A1 (sl)
AT (1) ATE345817T1 (sl)
AU (1) AU2003208713B2 (sl)
BR (1) BR0307278A (sl)
CA (1) CA2472744A1 (sl)
DE (1) DE60309839T2 (sl)
DK (1) DK1476196T3 (sl)
ES (1) ES2277635T3 (sl)
HR (1) HRP20040613A2 (sl)
IL (2) IL162883A0 (sl)
MX (1) MXPA04007852A (sl)
NO (1) NO20043832L (sl)
PL (1) PL370452A1 (sl)
PT (1) PT1476196E (sl)
RU (1) RU2314811C2 (sl)
SI (1) SI1476196T1 (sl)
UA (1) UA79267C2 (sl)
WO (1) WO2003068266A1 (sl)
ZA (1) ZA200405608B (sl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
US8025899B2 (en) * 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
TW200633713A (en) * 2004-12-23 2006-10-01 Solvay Pharm Bv Oral immediate release formulation of a poorly water-soluble active substance
US20060159748A1 (en) * 2004-12-23 2006-07-20 Rajesh Jain Oral immediate release formulation of a poorly water-soluble active substance
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
JP2007308479A (ja) 2006-04-20 2007-11-29 Shin Etsu Chem Co Ltd 固体分散体製剤
AU2007259252A1 (en) * 2006-06-16 2007-12-21 Solvay Pharmaceuticals B.V. Oral pharmaceutical composition of a poorly water-soluble active substance
AU2007263016A1 (en) * 2006-06-22 2007-12-27 Panacea Biotec Ltd. Oral pharmaceutical composition of a poorly water-soluble active substance
AU2007271088A1 (en) * 2006-07-06 2008-01-10 Ares Trading S.A. An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof
US20080181959A1 (en) * 2006-09-01 2008-07-31 Ilan Zalit Solid composites of a calcium receptor-active compound
AR071375A1 (es) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
DK2600851T3 (en) 2010-08-04 2018-06-25 Gruenenthal Gmbh PHARMACEUTICAL DOSAGE FORM CONTAINING 6'-FLUORO- (N-METHYL OR N, N-DIMETHYL -) - 4-PHENYL-4 ', 9'-DIHYDRO-3'H-SPIRO [CYCLOHEXAN-1,1'-PYRANO [3,4, B] INDOL] -4-AMINE FOR TREATMENT OF NEUROPATHIC PAIN
RU2582390C2 (ru) * 2010-08-04 2016-04-27 Грюненталь Гмбх ЛЕКАРСТВЕННАЯ ДОЗИРОВАННАЯ ФОРМА, КОТОРАЯ СОДЕРЖИТ 6'-ФТОР-(N-МЕТИЛ-ИЛИ N,N-ДИМЕТИЛ-)-4-ФЕНИЛ-4', 9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1,1'-ПИРАНО[3,4,b]ИНДОЛ]-4-АМИН
CN107735080B (zh) * 2015-07-03 2020-10-23 浙江海正药业股份有限公司 一种人参皂苷c-k口服固体制剂及其制备方法
PL424452A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu
PL424453A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP)
HUE069633T2 (hu) 2018-11-30 2025-04-28 Chemocentryx Inc Kapszulás készítmények
WO2025018777A1 (ko) * 2023-07-18 2025-01-23 삼아제약 주식회사 프란루카스트 함유 약제학적 조성물의 제조방법 및 상기 제조방법에 의해 제조된 약제학적 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3359167A (en) * 1965-07-22 1967-12-19 Pfizer & Co C Vitamin a compositions
CU35543A1 (es) * 1980-10-09 1983-05-05 Hoffmann La Roche Prostaglandines
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
TW426516B (en) * 1996-12-06 2001-03-21 Fujisawa Pharmaceutical Co An oral pharmaceutical composition in solid dispersion containing water-insoluble tricyclic compounds
GB2355195B (en) * 1997-01-30 2001-09-12 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
KR100336090B1 (ko) * 1998-06-27 2002-05-27 윤승원 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen
US20010036959A1 (en) * 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions

Also Published As

Publication number Publication date
CN1273194C (zh) 2006-09-06
RU2314811C2 (ru) 2008-01-20
AU2003208713B9 (en) 2003-09-04
MXPA04007852A (es) 2004-10-15
EP1476196B1 (en) 2006-11-22
NO20043832L (no) 2004-09-13
UA79267C2 (en) 2007-06-11
HK1077218A1 (en) 2006-02-10
IL162883A (en) 2009-05-04
CA2472744A1 (en) 2003-08-21
US20050008697A1 (en) 2005-01-13
RU2004127457A (ru) 2005-04-20
DE60309839D1 (de) 2007-01-04
AU2003208713B2 (en) 2007-10-18
AR038681A1 (es) 2005-01-26
WO2003068266A1 (en) 2003-08-21
JP2005517041A (ja) 2005-06-09
US20110086844A1 (en) 2011-04-14
EP1476196A1 (en) 2004-11-17
KR20040085193A (ko) 2004-10-07
CN1633307A (zh) 2005-06-29
PT1476196E (pt) 2007-02-28
IL162883A0 (en) 2005-11-20
ATE345817T1 (de) 2006-12-15
DE60309839T2 (de) 2007-03-15
AU2003208713A1 (en) 2003-09-04
KR101014545B1 (ko) 2011-02-16
HRP20040613A2 (en) 2005-04-30
DK1476196T3 (da) 2007-03-05
ES2277635T3 (es) 2007-07-16
PL370452A1 (en) 2005-05-30
BR0307278A (pt) 2004-12-28
ZA200405608B (en) 2005-06-24

Similar Documents

Publication Publication Date Title
IL162883A0 (en) Oral solid solution formulation of a poorly water-soluble active substance
TWI319319B (en) New solid pharmaceutical formulations comprising telmisartan and preparation thereof
AU2003229555A1 (en) Oral administration form for difficulty soluble basic active ingredients which are applied orally
EP1483277A4 (en) CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS OF PREPARATION AND USE, AND FORMULATION AND PHARMACEUTICAL APPLICATIONS
IL163642A0 (en) Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
AU2003252299A8 (en) Novel physiologically active substance
EP1483579A4 (en) CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS FOR THE PREPARATION AND USE OF CONJUGATES, FORMULATION AND PHARMACEUTICAL APPLICATIONS OBTAINED FROM SUCH CONJUGATES
SI1608362T1 (sl) Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino
HUP0303948A2 (hu) Szájban diszpergálódó szilárd gyógyszerforma
EP1750680A4 (en) FORMULATIONS OF WATER-SOLUBLE AGENTS COATED WITH SLOW RELEASE COMPRESSION
HUP0500638A3 (en) Flashmelt oral dosage formulation
EP1496863A4 (en) ELABORATION AND USE OF STABLE FORMULATION OF ALLOSTERICALLY EFFECTIVE COMPOUNDS
IL165069A0 (en) Immediate release pharmaceutical formulation
GB2388541B (en) Aerosol formulations containing a particulate active substance
AU2003295846A8 (en) Pharmaceutical formulations of celcoxib
PL1848439T3 (pl) Doustna formulacja o natychmiastowym uwalnianiu słabo rozpuszczalnej w wodzie substancji aktywnej
ZA200705021B (en) Oral immediate release formulation of a poorly water-soluble active substance
GB0225926D0 (en) Pharmaceutical paste formulations
IL183554A0 (en) Oral immediate formulation of a poorly watersoluble active substance
AU2002339720A1 (en) Improved pharmaceutical dental formulations
HRP20040757A2 (en) A stable pharmaceutical formulation comprising torsemide modification ii
GB0225702D0 (en) Oral formulation of moisutre-sensitive drugs
AU2001283438A1 (en) A method of stabilizing a dry powder pharmaceutical formulation
ZA200508282B (en) Method of preparing a formulation containing a microdosed active principle
AU2003254672A8 (en) Dual-spike release formulation for oral drug delivery